Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Warr

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesisD Warr, A Willan, S Fine, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancerM N Levine, V Bramwell, K Pritchard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1995
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapyJ Latreille, D Stewart, F Laberge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapyJ Rusthoven, J Pater, L Kaizer, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancerU Sagman, R Feld, W K Evans, et al.
The New England Journal of Medicine|April 15, 1993
Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracilM Levitt, D Warr, L Yelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Small-cell carcinoma of the lung: derivation of a prognostic staging systemU Sagman, E Maki, W K Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimenE Warner, D Hedley, I Andrulis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials GroupJ Latreille, J Pater, D Johnston, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesisD Warr, A Willan, S Fine, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancerM N Levine, V Bramwell, K Pritchard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1995
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapyJ Latreille, D Stewart, F Laberge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapyJ Rusthoven, J Pater, L Kaizer, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancerU Sagman, R Feld, W K Evans, et al.
The New England Journal of Medicine|April 15, 1993
Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracilM Levitt, D Warr, L Yelle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Small-cell carcinoma of the lung: derivation of a prognostic staging systemU Sagman, E Maki, W K Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimenE Warner, D Hedley, I Andrulis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials GroupJ Latreille, J Pater, D Johnston, et al.
Pageof 5